Peripheral Vascular DiseaseThe InSpectra™ StO2 Tissue Oxygenation Monitor has not been cleared by the FDA for use in diagnosing peripheral vascular disease. Additional clinical studies are required to establish the value of these measurements in assessing patient status relating to peripheral vascular disease. Click here to see the complete Indications for Use.
Tissue (Muscle) Oxygen Saturation StO2: A New Measure Of Symptomatic Lower-Extremity Arterial Disease
Comerota AJ, Throm RC, Kelly P, Jaff M J Vasc Surg.
A study comparing patients with peripheral arterial disease (PAD) to normal patients demonstrates the potential value of the InSpectra
™ System for assessing compromised circulation.